A New Oral GLP-1 Medication: What It Means for Weight Loss and Metabolic Health

Apr 16

💊 A new option just dropped: the second oral GLP-1 medication, Orforglipron, has received FDA approval.

For patients who are needle-averse, this is a meaningful step forward.

I’ll be honest- I was initially skeptical of GLP-1 medications. But over time, I’ve seen some truly impressive outcomes.

On average, patients are achieving ~10–15% weight loss, along with improvements in metabolic health.

With over 40% of U.S. adults affected by obesity, this isn’t just about weight- it’s about reducing risk for:

• Heart disease

• Type 2 diabetes

• Fatty liver disease

• Hypertension

• Cognitive decline

That said- medication is not the starting point.

At Hearthstone Family Care, we take a root-cause, personalized approach:

We look at factors like:

• Nutrition and ultra-processed foods

• Sleep and stress

• Hormonal balance

• Insulin resistance

• Inflammation

Often, addressing these leads to meaningful progress.

But when progress plateaus, GLP-1 medications can be a powerful tool.

Like any therapy, they’re not for everyone- and they work best as part of a comprehensive plan.

If you’ve been struggling with weight and want a personalized approach, I’d be happy to talk.

#weightloss #DPC #HearthstoneFamilyCare #DrLarryMiller

#FunctionalMedicine#HolisticFamilyPhysician

Larry Miller

Spring Allergies: Why It’s Not Just Pollen- and What You Can Do About It